{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-085393","form_type":"8-K","ticker":"HSCS","cik":"0001468492","company_name":"HeartSciences Inc.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.156137+00:00","generated_at":"2026-06-08T04:55:45.655911+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Heart Test Labs amends ATM facility to allow up to $10M in common stock sales","bullets":["Amended Equity Distribution Agreement with Maxim Group raises offering cap from $3.25M to $10M.","Company previously sold the full $3.25M (11,065,416 shares) under the original agreement.","Shares sold under the at-the-market offering; legal fees reimbursement to Maxim capped at $65,000.","Offering registered on Form S-3; subject to one-third of non-affiliate market value limit per I.B.6.","As of Nov 9, non-affiliate market value was ~$18M based on 21.2M shares and $0.85 close price."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-085393","json":"https://secwatch.observer/filing/0001213900-23-085393.json","markdown":"https://secwatch.observer/filing/0001213900-23-085393.md","text":"https://secwatch.observer/filing/0001213900-23-085393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468492/000121390023085393/0001213900-23-085393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468492/000121390023085393/ea187969-8k_hearttest.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T04:55:45.655911+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"95d31638c057098b8cee479ae43e8d0196e1f65a","claim":"HeartSciences Inc. amended Amended EDA with Maxim Group LLC valued at up to $10,000,000 (effective 2023-11-09).","evidence_excerpt":"On November 9, 2023, the Company entered into Amendment No. 1 to the Original EDA (the “Amended EDA” and together with the Original EDA, the “EDA”) with Maxim Group pursuant to which the Company may issue and sell up to $10,000,000 of its shares of Common Stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468492/000121390023085393/0001213900-23-085393-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Maxim Group LLC"},{"label":"Value","value":"up to $10,000,000"},{"label":"Effective","value":"2023-11-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}